Interim Treatment Change Options for GU Malignancies During the COVID-19 Pandemic –
Endorsed by NHS England- Nicholas James, who gives insight into the COVID-19 pandemic and how it is affecting cancer care in London, England, as well as the Institute of Cancer Research (ICR) guidelines that Nick James and his group have put forth to really improve or, at least, standardize the care for patients with cancer during this time. By calling for modified treatment plans, Nicholas James highlights the goal was to allow for greater flexibility in the management of cancer during the COVID-19 pandemic to ensure clinicians have additional treatment options through this time.
